September 2026
The U.S. concierge medicine market generated USD 6.99 billion in 2026, with prominent U.S. concierge medicine market companies including Priority Physicians, Inc., Castle Connolly Private Health Partners, PartnerMD, Concierge Consultants and CardiologyÂ
September 2026
The global concierge medicine market size is expected to increase from USD 23.23 billion in 2026 and is projected to hit around USD 41.37 billion by 2035 with a CAGR of 6.63%.
September 2026
The U.S. regenerative medicine market was worth USD 24.10 billion in 2026, with key U.S. regenerative medicine market players including Integra LifeSciences Corporation (U.S.), Bristol-Myers Squibb Company (U.S.), American CryoStem Corporation (U.S.).
September 2026
The U.S. personalized medicine market generated USD 207.15 billion in 2026, with prominent U.S. personalized medicine market companies including Thermo Fisher Scientific, Illumina, Johnson and Johnson.
June 2025
The U.S. precision medicine market size surpassed USD 49.79 billion in 2024 and is predicted to reach around USD 232.49 billion by 2034 with a solid CAGR of 16.66%.
September 2026
The photomedicine devices and technologies market size is expected to hit around USD 11.44 billion by 2034 from USD 4.99 billion in 2026, with a CAGR of 10.91%.
September 2026
The U.S. nitrogenous fertilizer market size surpassed USD 12,092.30 million in 2026 and is predicted to be worth around USD 14,902.41 million by 2035 with a CAGR of 2.39%.
September 2026
The global bioelectric medicine market size was estimated at USD 27.31 billion in 2026 and is expected to hit around USD 50.13 billion by 2035, with a CAGR of 7%.
September 2026
The global non-oncology precision medicine market size is calculated at USD 101.25 billion in 2026 and is projected to hit around USD 222.95 billion by 2035 with a CAGR of 9.23%.
September 2026
The global nuclear medicine market size was exhibited at USD 14.72 billion in 2026 and is expected to hit around USD 38.39 billion by 2035 with a noteworthy CAGR of 11.26%.
September 2026
The U.S. corporate wellness market size is expected to increase to USD 44.24 billion by 2035 from USD 24.85 billion in 2025, with a CAGR of 6.59%.
September 2026
The global U.S. oral care market size is calculated at USD 11.11 billion in 2026 and is projected to hit around USD 16.60 billion by 2035 with a CAGR of 4.57%.
September 2026
The U.S. digital therapeutics market size is exhibited at USD 4.56 billion in 2026 and is predicted to surpass USD 24.09 billion by 2035 with a remarkable CAGR of 20.54%.
September 2026
The U.S. point of care infectious disease testing market size is projected to hit around USD 5.27 billion by 2035, growing at a CAGR of 8.98% from 2026 to 2035.
September 2026
The AI in telemedicine market was worth USD 32.30 billion in 2026, with key AI in telemedicine market players including IBM Corporation, Microsoft Corporation.
September 2026
The nuclear medicine software market size reached USD 1,069.01 million in 2026, with leading nuclear medicine software market companies including GE Healthcare, Siemens Healthineer.
September 2026
The U.S. pharmaceutical market was valued at USD 552.72 billion in 2026, with leading companies including Johnson & Johnson, Pfizer, Merck & Co., AbbVie, Bristol Myers Squibb, Eli Lilly.
September 2026
The global geriatric medicines market size is expected to increase from USD 195.36 billion in 2026 to hit around USD 348.40 billion by 2035, with a CAGR of 7.50%.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The global personalized medicine market was estimated at USD 702.52 billion in 2026 and is expected to hit around USD 1397.63 billion by 2035, at a CAGR of 7.88%%.
September 2026
The U.S. hospital emergency department market is estimated to hit around USD 307.63 billion by 2035 increasing from USD 190.70 billion in 2026, with a CAGR of 5.44%.
September 2026
The global nanomedicine market size was calculated at USD 260.79 billion in 2026 and is projected to hit around USD 687.64 billion by 2035 with a CAGR of 11.4%.
September 2026
The U.S. pharmacy benefit management market was valued at USD 504.08 billion in 2026, with leading companies including Cigna Group, CVS Health, MedImpact.
September 2026
The U.S. AI materials product optimization market expands with innovations in computational modeling, automated labs, and AI-driven material design.
September 2026
The U.S. complex and chronic condition management market size is valued at USD 7.47 billion in 2026 and is expected to reach over USD 18.33 billion by 2035, with a registered CAGR of 11.18%.
September 2026
The global telemedicine market size is anticipated at USD 188.93 billion in 2026 and is hit around USD 806.89 billion by 2035, expanding at a CAGR of 17.55%.
September 2026
The US dental services market size is calculated at USD 185.39 billion in 2026 and is expected to surpass USD 281.20 billion by 2035, growing at a CAGR of 4.86%.
September 2026
The global complementary and alternative medicine market size is valued at USD 241.70 billion in 2026 and is expected to hit around USD 1,412.89 billion by 2035 with a CAGR of 22.00%.
September 2026
The U.S. acute hospital care market size is expected to attain around USD 2.57 trillion by 2035 from USD 1.45 trillion in 2026 with a notable CAGR of 6.65%.
September 2026
The U.S. investment banking and asset management market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com